• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于评估复发缓解型多发性硬化症患者病情进展风险的新型预后评分。

A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients.

作者信息

Pisani Anna Isabella, Scalfari Antonio, Crescenzo Francesco, Romualdi Chiara, Calabrese Massimiliano

机构信息

Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.

Brain Division, Imperial College London, London, UK.

出版信息

Eur J Neurol. 2021 Aug;28(8):2503-2512. doi: 10.1111/ene.14859. Epub 2021 May 5.

DOI:10.1111/ene.14859
PMID:33835665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8360167/
Abstract

BACKGROUND

At the patient level, the prognostic value of several features that are known to be associated with an increased risk of converting from relapsing-remitting (RR) to secondary phase (SP) multiple sclerosis (MS) remains limited.

METHODS

Among 262 RRMS patients followed up for 10 years, we assessed the probability of developing the SP course based on clinical and conventional and non-conventional magnetic resonance imaging (MRI) parameters at diagnosis and after 2 years. We used a machine learning method, the random survival forests, to identify, according to their minimal depth (MD), the most predictive factors associated with the risk of SP conversion, which were then combined to compute the secondary progressive risk score (SP-RiSc).

RESULTS

During the observation period, 69 (26%) patients converted to SPMS. The number of cortical lesions (MD = 2.47) and age (MD = 3.30) at diagnosis, the global cortical thinning (MD = 1.65), the cerebellar cortical volume loss (MD = 2.15) and the cortical lesion load increase (MD = 3.15) over the first 2 years exerted the greatest predictive effect. Three patients' risk groups were identified; in the high-risk group, 85% (46/55) of patients entered the SP phase in 7 median years. The SP-RiSc optimal cut-off estimated was 17.7 showing specificity and sensitivity of 87% and 92%, respectively, and overall accuracy of 88%.

CONCLUSIONS

The SP-RiSc yielded a high performance in identifying MS patients with high probability to develop SPMS, which can help improve management strategies. These findings are the premise of further larger prospective studies to assess its use in clinical settings.

摘要

背景

在患者层面,已知与复发缓解型(RR)多发性硬化症(MS)转变为继发进展型(SP)风险增加相关的若干特征的预后价值仍然有限。

方法

在262例接受了10年随访的RRMS患者中,我们根据诊断时及2年后的临床、传统和非传统磁共振成像(MRI)参数评估了发展为SP病程的概率。我们使用一种机器学习方法——随机生存森林,根据其最小深度(MD)识别与SP转化风险相关的最具预测性的因素,然后将这些因素结合起来计算继发进展风险评分(SP-RiSc)。

结果

在观察期内,69例(26%)患者转变为SPMS。诊断时的皮质病变数量(MD = 2.47)和年龄(MD = 3.30)、前2年的整体皮质变薄(MD = 1.65)、小脑皮质体积减少(MD = 2.15)以及皮质病变负荷增加(MD = 3.15)具有最大的预测作用。确定了三个患者风险组;在高风险组中,85%(46/55)的患者在7年中位数时间内进入SP期。估计的SP-RiSc最佳截断值为17.7,特异性和敏感性分别为87%和92%,总体准确率为88%。

结论

SP-RiSc在识别极有可能发展为SPMS的MS患者方面表现出色,这有助于改进管理策略。这些发现是进一步开展更大规模前瞻性研究以评估其在临床环境中应用的前提。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1784/8360167/26f9ac873ff3/ENE-28-2503-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1784/8360167/b54ad47b28d0/ENE-28-2503-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1784/8360167/35ad83e94ae5/ENE-28-2503-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1784/8360167/26f9ac873ff3/ENE-28-2503-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1784/8360167/b54ad47b28d0/ENE-28-2503-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1784/8360167/35ad83e94ae5/ENE-28-2503-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1784/8360167/26f9ac873ff3/ENE-28-2503-g003.jpg

相似文献

1
A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients.一种用于评估复发缓解型多发性硬化症患者病情进展风险的新型预后评分。
Eur J Neurol. 2021 Aug;28(8):2503-2512. doi: 10.1111/ene.14859. Epub 2021 May 5.
2
Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning.复发缓解型与继发进展型多发性硬化的鉴别:基于机器学习的磁共振波谱研究
Arq Neuropsiquiatr. 2020 Dec;78(12):789-796. doi: 10.1590/0004-282X20200094.
3
Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.认知功能障碍和脑萎缩的复合标志物在区分复发缓解型和继发进展型多发性硬化症方面具有高度准确性。
Med Sci Monit. 2017 Feb 1;23:588-597. doi: 10.12659/msm.903234.
4
Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.在复发缓解型多发性硬化症中,颈髓区域主要与幕下灰质和白质体积相关:一项使用半自动脊髓容积测量法和基于体素的形态测量学的研究
Mult Scler Relat Disord. 2015 May;4(3):264-72. doi: 10.1016/j.msard.2015.04.003. Epub 2015 Apr 15.
5
Early predictors of conversion to secondary progressive multiple sclerosis.继发进展型多发性硬化早期预测指标。
Mult Scler Relat Disord. 2021 Sep;54:103115. doi: 10.1016/j.msard.2021.103115. Epub 2021 Jun 26.
6
Mitoxantrone: a review of its use in multiple sclerosis.米托蒽醌:其在多发性硬化症中的应用综述
CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010.
7
Application of definitions for conversion to secondary progressive MS in a Danish nationwide population.定义在丹麦全国人群中的继发进展型多发性硬化转化中的应用。
Mult Scler Relat Disord. 2021 Nov;56:103319. doi: 10.1016/j.msard.2021.103319. Epub 2021 Oct 10.
8
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.干扰素β与醋酸格拉替雷治疗复发缓解型多发性硬化症的对比
Cochrane Database Syst Rev. 2016 Nov 24;11(11):CD009333. doi: 10.1002/14651858.CD009333.pub3.
9
[Neuropsychological and MRI diagnostics in secondary progressive multiple sclerosis].继发性进展型多发性硬化症的神经心理学与磁共振成像诊断
Nervenarzt. 2021 Dec;92(12):1293-1301. doi: 10.1007/s00115-021-01118-9. Epub 2021 Apr 23.
10
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.局灶性颈脊髓病变累及灰质与进展型多发性硬化症相关。
Mult Scler. 2016 Jun;22(7):910-20. doi: 10.1177/1352458515604905. Epub 2015 Oct 2.

引用本文的文献

1
Assessing the role of volumetric brain information in multiple sclerosis progression.评估脑容量信息在多发性硬化症进展中的作用。
Comput Struct Biotechnol J. 2025 May 12;27:2014-2033. doi: 10.1016/j.csbj.2025.05.003. eCollection 2025.
2
Predictors of early disability accumulation in newly diagnosed multiple sclerosis: clinical, imaging and cerebrospinal fluid measures.新诊断多发性硬化症早期残疾累积的预测因素:临床、影像学和脑脊液指标
J Neurol Neurosurg Psychiatry. 2025 Feb 17. doi: 10.1136/jnnp-2024-335037.
3
Early clinical effect of cladribine in patients with highly active multiple sclerosis in Mexico.

本文引用的文献

1
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.在两项随机临床试验的汇总分析中,复发无关进展与复发相关恶化对典型复发型多发性硬化症总体确认残疾累积的贡献。
JAMA Neurol. 2020 Sep 1;77(9):1132-1140. doi: 10.1001/jamaneurol.2020.1568.
2
The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity.与皮质损伤相关的 CSF 特征可预测多发性硬化症的活动。
Ann Neurol. 2020 Sep;88(3):562-573. doi: 10.1002/ana.25786. Epub 2020 Jul 9.
3
Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors.
克拉屈滨在墨西哥高度活动性多发性硬化症患者中的早期临床疗效。
Mult Scler J Exp Transl Clin. 2024 Aug 1;10(3):20552173241260156. doi: 10.1177/20552173241260156. eCollection 2024 Jul-Sep.
4
Decoding Gray Matter Involvement in Multiple Sclerosis via Imaging.通过成像技术解码多发性硬化症中灰质的受累情况。
Neuroimaging Clin N Am. 2024 Aug;34(3):453-468. doi: 10.1016/j.nic.2024.03.007. Epub 2024 May 19.
5
Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing-remitting multiple sclerosis: a 20-year follow-up cohort.基线血清神经丝轻链水平可区分复发缓解型多发性硬化的侵袭性和良性形式:一项 20 年随访队列研究。
J Neurol. 2024 Apr;271(4):1599-1609. doi: 10.1007/s00415-023-12135-w. Epub 2023 Dec 12.
6
Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China.中国多发性硬化症在流行病学、临床特征及治疗方面的最新进展
Ther Adv Neurol Disord. 2023 Sep 15;16:17562864231193816. doi: 10.1177/17562864231193816. eCollection 2023.
7
Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis.用于预测多发性硬化症患者临床疾病进展、恶化和活动的预后模型。
Cochrane Database Syst Rev. 2023 Sep 8;9(9):CD013606. doi: 10.1002/14651858.CD013606.pub2.
8
Linking lesions in sensorimotor cortex to contralateral hand function in multiple sclerosis: a 7 T MRI study.多 sclerosis 中感觉运动皮层病灶与对侧手功能的关联:7 T MRI 研究。
Brain. 2022 Oct 21;145(10):3522-3535. doi: 10.1093/brain/awac203.
9
Predictive MRI Biomarkers in MS-A Critical Review.MRI 预测生物标志物在 MS 中的应用——批判性综述。
Medicina (Kaunas). 2022 Mar 3;58(3):377. doi: 10.3390/medicina58030377.
10
Imaging cortical multiple sclerosis lesions with ultra-high field MRI.超高场 MRI 成像皮质多发性硬化病变。
Neuroimage Clin. 2021;32:102847. doi: 10.1016/j.nicl.2021.102847. Epub 2021 Oct 6.
利用遗传和非遗传因素预测继发进展性多发性硬化症的发病。
J Neurol. 2020 Aug;267(8):2328-2339. doi: 10.1007/s00415-020-09850-z. Epub 2020 Apr 24.
4
Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.复发缓解型多发性硬化症长期预后的早期影像学预测指标。
Brain. 2019 Aug 1;142(8):2276-2287. doi: 10.1093/brain/awz156.
5
Silent progression in disease activity-free relapsing multiple sclerosis.疾病活动无复发缓解型多发性硬化的静息进展。
Ann Neurol. 2019 May;85(5):653-666. doi: 10.1002/ana.25463. Epub 2019 Mar 30.
6
Predicting risk of secondary progression in multiple sclerosis: A nomogram.预测多发性硬化症的继发进展风险:列线图。
Mult Scler. 2019 Jul;25(8):1102-1112. doi: 10.1177/1352458518783667. Epub 2018 Jun 18.
7
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis.多发性硬化症的皮质损伤、早期复发和进展阶段的发生。
Neurology. 2018 Jun 12;90(24):e2107-e2118. doi: 10.1212/WNL.0000000000005685. Epub 2018 May 16.
8
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.多发性硬化症中的炎症性鞘内特征和皮质损伤。
Ann Neurol. 2018 Apr;83(4):739-755. doi: 10.1002/ana.25197.
9
Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach.基于机器学习方法的类风湿关节炎死亡率的多变量预测模型的建立和验证。
Sci Rep. 2017 Aug 31;7(1):10189. doi: 10.1038/s41598-017-10558-w.
10
Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis.实践中的随机生存森林:一种在时间-事件分析中对复杂代谢组学数据进行建模的方法。
Int J Epidemiol. 2016 Oct;45(5):1406-1420. doi: 10.1093/ije/dyw145. Epub 2016 Sep 1.